- Published on 12 June 2018
The Soreq Applied Research Accelerator Facility (SARAF) is under construction in the Soreq Nuclear Research Center at Yavne, Israel. Phase I of SARAF (SARAF-I) is already in operation, generating scientific results in several fields of interest, especially the astrophysical s-process. When completed at the beginning of the next decade, SARAF-II will be a user facility for basic and applied nuclear physics, based on a 40 MeV, 5 mA CW proton/deuteron superconducting linear accelerator. This review presents first a technical overview of SARAF-I and II, including a description of the accelerator and its irradiation targets, and provides a survey of existing research programs at SARAF-I. It then describes in some detail the research potential at the completed facility. SARAF-II’s cutting-edge specifications, with its unique liquid lithium target technology, will enable world-competitive research plans in several disciplines: precision studies of beyond-Standard-Model effects by trapping light exotic radioisotopes (including meaningful studies already at SARAF-I); extended nuclear astrophysics research with higher-energy neutrons, including generation and studies of exotic neutron-rich isotopes relevant to the astrophysical r-process; nuclear structure of exotic isotopes; high-energy neutron cross sections for basic nuclear physics and material science research, including neutron-induced radiation damage; neutron-based imaging with an imaging plane flux similar to that of a 5 MW research reactor; accelerator-based neutron therapy; and, last but not least, novel radiopharmaceuticals development and production.
Israel Mardor et al. (2018), The Soreq Applied Research Accelerator Facility (SARAF): Overview, research programs and future plans, European Physical Journal A 54: 91, DOI 10.1140/epja/i2018-12526-2